Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anatomy of a Flagship Asset: Theralase

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Mar 31, 2023 8:40pm

142 Views

Post# 35373132

RE:Anatomy of a Flagship Asset: Theralase

Thanks Nailbiter2. Great to see this article at this point (dated about a week ago). Hopefully will have an impact on TLT's visibilty. I was also glad to see the comments in last paragraph about 'coole laser therapy'...which they describe as 'viable'. Haven't followed cool laser stuff for awhile...I hope they're right and it's contributing at this point...

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly